Liminatus Pharma, Inc. (LIMN)
0.75
-0.01
(-1.17%)
USD |
NASDAQ |
Jan 14, 16:00
0.7897
+0.04
(+5.29%)
Pre-Market: 08:30
Liminatus Pharma Price: 0.75 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CDT Equity, Inc. | 1.40 |
| LENZ Therapeutics, Inc. | 18.59 |
| Oruka Therapeutics, Inc. | 32.00 |
| Maze Therapeutics, Inc. | 41.11 |
| MapLight Therapeutics, Inc. | 18.76 |
Price Related Metrics
| PEG Ratio | -0.1178 |
| Earnings Yield | -24.71% |
| Market Cap | 20.30M |
| PEGY Ratio | -0.1178 |